Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study

De Corte, ThomasThomasDe CorteVerhaeghe, JarneJarneVerhaegheDhaese, SofieSofieDhaeseVan Vooren, SarahSarahVan VoorenBoelens, JerinaJerinaBoelensG. Verstraete, AlainAlainG. VerstraeteStove, VeroniqueVeroniqueStoveOngenae, FemkeFemkeOngenaeDe Bus, LiesbetLiesbetDe BusDepuydt, PieterPieterDepuydtVan Hoecke, SofieSofieVan HoeckeJ. De Waele, JanJanJ. De Waele2023-07-102023-05-152023-05-162023-07-1020232110-5820WOS:000976160400001https://imec-publications.be/handle/20.500.12860/41592Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational studyJournal article10.1186/s13613-023-01129-6WOS:000976160400001CARE-UNIT PATIENTSMEDLINE:37119362